Bailian Liu
Overview
Explore the profile of Bailian Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pu X, Geng C, Xiao W, Gu S, Wang D, Liu C, et al.
Eur Spine J
. 2024 Oct;
34(1):17-26.
PMID: 39476030
Purpose: The study aims to investigate the correlations between the T score, Hounsfield units (HU) value, and vertebral bone quality (VBQ) score, and to compare their discrimination capability for patients...
2.
Yu D, Chen L, Li Y, Liu B, Xiao W
Anticancer Drugs
. 2024 Jul;
35(10):893-901.
PMID: 39016842
The current treatment for osteosarcoma (OS) is based on surgery combined with systemic chemotherapy, however, gene therapy has been hypothesized to improve patient survival rates. The density-enhanced protein domain 1...
3.
Pu X, Liu B, Wang D, Xiao W, Liu C, Gu S, et al.
Osteoporos Int
. 2024 Jun;
35(9):1625-1631.
PMID: 38942897
Introduction: The purpose of this study is to determine whether the opportunistic use of computed tomography (CT) or magnetic resonance imaging (MRI) is effective for identifying spine surgical patients with...
4.
Pu X, Wang D, Xiao W, Liu B
Eur Spine J
. 2023 Jun;
32(9):3315-3316.
PMID: 37347279
No abstract available.
5.
6.
Dai X, Guan Y, Zhang Z, Xiong Y, Liu C, Li H, et al.
Exp Ther Med
. 2021 Aug;
22(3):1018.
PMID: 34373704
Nucleus pulposus cell (NPC) transplantation can be a potential therapeutic approach for intervertebral disc degeneration (IDD). However, low cell viability has restricted the therapeutic capacity of NPCs, and sources of...
7.
Yu S, Fu S, Liu B, Zhang Y, Zhou G
Nat Prod Res
. 2015 Feb;
29(14):1336-41.
PMID: 25656831
Two new quercetin glycoside derivatives named quercetin-3-O-[2-O-trans-caffeoyl-α-L-rhamnopyranosyl-(1 → 6)-β-D-glucopyranoside] (1) and quercetin-3-O-[2-O-trans-caffeoyl-β-L-rhamnopyranosyl-(1 → 6)-β-D-glucopyranoside] (2) along with three known flavonoids, 5-hydroxy-6,7,3',4',5'-pentamethoxyflavone (3), 5,7-dihydroxy-8-methoxyflavone (4) and kaempferol 3-O-β-D-glucopyranoside (5), were isolated...
8.
Cao C, Liu B, Zeng C, Lu Y, Chen S, Yang L, et al.
Cancer Cell Int
. 2014 Dec;
14(1):137.
PMID: 25530716
Background: Treatment with imatinib mesylate (IM) (a tyrosine kinase inhibitor) is the first line of standard care for patients newly diagnosed with CML. Despite the success of IM and other...
9.
Liu B, Xiong Y, Deng H, Gu S, Jia F, Li Q, et al.
J Orthop Surg Res
. 2014 Jul;
9:47.
PMID: 25047454
Objective: The purpose of this study is to compare the clinical effects of our self-designed rotary self-locking intramedullary nail (RSIN) and interlocking intramedullary nail (IIN) for long bone fractures. Methods:...
10.
Wang D, Xiong Y, Deng H, Liu B, Li Q, Zhang Z, et al.
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
. 2011 Aug;
25(7):811-5.
PMID: 21818946
Objective: To improve the retrograde rotative-type interlocking intramedullary nail based on humeral bone dissection and clinical application, and investigate the clinical values of modified retrograde rotative-type interlocking intramedullary nail for...